TPCP (Turin Prostate Cancer Prognostication): “An integrated approach for improving the prognosis of prostate cancer” is an observational non-pharmacological retrospective cohort study whose objective is to address the need to improve the prognosis of prostate cancer, both in terms of identification of new prognostic markers and in terms of improvement of current prognostic models.
The Turin Prostate Cancer Prognostication (TPCP) is a study promoted by the Department of Medical Sciences of the University of Turin, funded by the AIRC Foundation for Cancer Research and launched in 2021 at the AOU Città della Salute e della Scienza of Turin.

Contacts:

Contacts: Lorenzo Richiardi
web site: studio TPCP